MarketLens
Sign Up

Why is Cathie Wood Shifting from Tech to Biotech

8 months ago
SHARE THIS ON:

Why is Cathie Wood Shifting from Tech to Biotech

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•2 weeks ago

Cathie Wood Sold $110 Million of AMD and Bought Nvidia Instead

Cathie Wood sold $110M of AMD and bought Nvidia, rotating from a top AI winner into a laggard. The swap signals where she sees remaining AI upside.
Stock News•2 months ago

Cathie Wood Is Buying This Up-and-Coming Biotech Stock. Should You Follow Her Lead?

Beam Therapeutics' expanding pipeline may reward patient investors, per Cathie Wood's recent purchase. The biotech's base-editing platform targets multiple genetic diseases.
Stock News•3 months ago

Why Pure-Play Healthcare Technology Innovation Matters

The ROBO Global Healthcare Technology and Innovation ETF (HTEC) offers targeted exposure to the global healthcare innovation value chain, as portfolios are commonly underexposed to this high-growth op...

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

Greg Abel Made Major Additions to Alphabet and Delta Last Quarter While Berkshire Bought Back $4.4 Billion of Its Own Stock. Is This a Buying Signal Investors Should Watch?

Stock News•3 hours ago

Lightbridge (LTBR) CEO on CEG & GOOGL Nuclear Energy Deal, Global Expansion

Stock News•4 hours ago

Apple's Market Value Grew From $350 Billion to $5 Trillion During Tim Cook's 15 Years as CEO. Here's What That Growth Curve Means for Apple's Next Chapter Under John Ternus.

Stock News•5 hours ago

GOOGL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Alphabet Investors of Securities Class Action Lawsuit Deadline on November 30, 2026

Stock News•6 hours ago

PLTR Unique Value in Volatile AI Trade, New NVDA & NBIS Partnerships